John L. Marshall MD, of Lombardi Comprehensive Cancer Center discusses how checkpoint inhibitors are being integrated into gastrointestinal cancers at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.
John L. Marshall MD, of Lombardi Comprehensive Cancer Center discusses how checkpoint inhibitors are being integrated into gastrointestinal cancers at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.